Twitter ACG 2010 Updates

Article

Newsletter

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Subscribe Now!
Recent Videos
Related Content
IV Ketamine Formulation NRX-100 Gains FDA Fast Track for Suicidal Depression / image credit ©Victority/stock.adobe.com

IV Ketamine NRX-100 Gains FDA Fast Track for Suicidal Depression

Grace Halsey
August 12th 2025
Article
The Weekly Dose: Pediatric Vaccine Safety, Atopic Dermatitis, Dementia Risk, and Maternal Depression

The Weekly Dose: Pediatric Vaccine Safety, Atopic Dermatitis, Dementia Risk, and Maternal Depression

Sydney Jennings
August 12th 2025
Podcast
Nirsevimab Cuts RSV Risk in Healthy Newborns: Daily Dose / image credit: ©New Africa/AdobeStock

Nirsevimab Cuts RSV Risk in Healthy Newborns: Daily Dose

Sydney Jennings
August 12th 2025
Article
Make It Routine: Screening for Cognitive Decline in Primary Care

Make It Routine: Screening for Cognitive Decline in Primary Care

Anna Chodos, MD, MPH;Sydney Jennings
August 12th 2025
Podcast
FDA Accepts Priority Review of Gepotidacin for Oral Treatment of Uncomplicated Urogenital Gonorrhea / Image credit: ©MohamadFaisal/AdobeStock

FDA Accepts Gepotidacin for Priority Review for the Treatment of Uncomplicated Urogenital Gonorrhea

Sydney Jennings
August 12th 2025
Article
Investigational Oral IL-23 Receptor Antagonist Icotrokinra Improves Skin Clearance in Psoriasis in Phase 3 Study / image credit Robert Bissonnette, MD, International Eczema Council

Investigational Oral IL-23 Receptor Antagonist Icotrokinra Improves Skin Clearance in Psoriasis in Phase 3 Study

Grace Halsey
August 12th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.